Uses

Used in the treatment of acute myeloid leukemia and other leukemias. It may also be used for prevention and treatment of meningeal leukemia.

Do not use if

Contraindicated in patients with known hypersensitivity to cytarabine.

Common effects include bone marrow suppression, anemia, leukopenia, thrombocytopenia, nausea, vomiting, and fever.

Should only be used under specialist oncology supervision. Severe bone marrow suppression and serious infections may occur.

Cytarabine is an antimetabolite that inhibits DNA synthesis, primarily affecting rapidly dividing cells during the S phase of the cell cycle.

Store at 20–25°C and protect from light.